G 341 (Oxybutynin chloride extended release 5 mg)
Pill imprint G 341 has been identified as Oxybutynin chloride extended release 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; dysuria; hyperhidrosis; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G 341 (Oxybutynin chloride extended release 5 mg)
Oxybutynin chloride extended release
- Imprint:
-
G 341
- Strength:
- 5 mg
- Color:
- Purple
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-5206
- Inactive Ingredients:
- hypromellose
lactose monohydrate
methacrylic acid
microcrystalline cellulose
magnesium silicate
triethyl citrate
FD&C Blue No. 2
FD&C Red No. 40
More resources
Oxybutynin chloride extended release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
